Communication
Structural Determination of NSC 670224, Synthesis of Analogues and Biological Evaluation
Article first published online: 29 FEB 2012
DOI: 10.1002/cmdc.201200038
Copyright © 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
Additional Information
How to Cite
Zuckerman, N. B., Myers, A. S., Quan, T. K., Bray, W. M., Lokey, R. S., Hartzog, G. A. and Konopelski, J. P. (2012), Structural Determination of NSC 670224, Synthesis of Analogues and Biological Evaluation. ChemMedChem, 7: 761–765. doi: 10.1002/cmdc.201200038
Publication History
- Issue published online: 25 APR 2012
- Article first published online: 29 FEB 2012
- Manuscript Received: 18 JAN 2012
Funded by
- US National Institutes of Health. Grant Number: 5R01GM084530-08
- University of California, Santa Cruz (USA)
Keywords:
- affinity probes;
- drug discovery;
- high-throughput screening;
- medicinal chemistry;
- tamoxifen

Follow my lead! NSC 670224, previously shown to be toxic to Saccharomyces cerevisiae at low micromolar concentrations, potentially acts via a mechanism of action related to that of tamoxifen (NSC 180973), breast cancer drug. The structure of NSC 670224, previously thought to be a 2,4-dichloro arene, was established as the 3,4-dichloro arene, and a focused library of analogues were synthesized and biologically evaluated.

1860-7187/asset/2452_left.gif?v=1&s=4110e7425ac5e40773dfb0778cfefa62f1594507)
1860-7187/asset/2452_right.gif?v=1&s=8458ea1f15af84217b579501ed7d7733bef04a94)
